The synthetic
triterpenoid 2-cyano-3, 12-dioxooleana-1, 9(11)-dien-C28-methyl
ester (
CDDO-Me) is considered a promising anti-tumorigenic compound. In this study, we show that treatment with
CDDO-Me induces progressive endoplasmic reticulum (ER)-derived vacuolation in various
breast cancer cells and ultimately kills these cells by inducing apoptosis. We found that
CDDO-Me-induced increases in intracellular Ca2+ levels, reflecting influx from the extracellular milieu, make a critical contribution to ER-derived vacuolation and subsequent cell death. In parallel with increasing Ca2+ levels,
CDDO-Me markedly increased the generation of
reactive oxygen species (ROS). Interestingly, there exists a reciprocal positive-regulatory loop between Ca2+ influx and ROS generation that triggers ER stress and ER dilation in response to
CDDO-Me. In addition,
CDDO-Me rapidly reduced the
protein levels of c-FLIPL (cellular
FLICE-inhibitory protein) and overexpression of c-FLIPL blocked
CDDO-Me-induced cell death, but not vacuolation. These results suggest that c-FLIPL downregulation is a key contributor to
CDDO-Me-induced apoptotic cell death, independent of ER-derived vacuolation. Taken together, our results show that ER-derived vacuolation via Ca2+ influx and ROS generation as well as
caspase activation via c-FLIPL downregulation are responsible for the potent anticancer effects of
CDDO-Me on
breast cancer cells.